Company intelligence / Profile preview

BroadPharm

San Diego, California, United Statesbroadpharm.com ↗

Ownership: Private
Employees: ~23
Development stage: Commercial

Overview

BroadPharm does not conduct clinical trials or develop therapeutics. It provides high-purity PEG linkers, click chemistry tools, ADC/PROTAC linkers, drug delivery lipids, fluorescent dyes, nucleosides and custom synthesis/bioconjugation services to support pharmaceutical and biotech R&D.

Therapeutic areas: Other
Modalities: Small molecule (PEG linkers and chemical reagents)Lipid nanoparticle delivery therapy (drug delivery lipids)Peptides (peptide synthesis services)Oligonucleotide (oligonucleotide synthesis services)Antibody-drug conjugate (ADC linker technology)Proteolysis-targeting chimera therapy (PROTAC linkers)
Industry: Chemicals & Materials

Partnerships

No major disclosed pharma/biotech partnerships; serves global clients in pharma/biotech sectors

Beyond the preview

Go deeper on BroadPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BroadPharm.

Explore the full profile